1 Min Read
NEW YORK, Jan 29 (Reuters) - Anacor Pharmaceuticals Inc : * Anacor Pharma down 22.6 percent to $4 in premarket after tavaborole trial results
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.